These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2143272)

  • 21. Conversion of arachidonic acid to tetradecadienoic acid by peroxisomal oxidation.
    Spector AA; Williard DE; Kaduce TL; Gordon JA
    Prostaglandins Leukot Essent Fatty Acids; 1997 Jul; 57(1):101-5. PubMed ID: 9250615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydroxyeicosatetraenoic acid metabolism in cultured human skin fibroblasts. Evidence for peroxisomal beta-oxidation.
    Gordon JA; Figard PH; Spector AA
    J Clin Invest; 1990 Apr; 85(4):1173-81. PubMed ID: 2318972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical biochemistry of peroxisomal disorders.
    Kaiser E; Kramar R
    Clin Chim Acta; 1988 Mar; 173(1):57-80. PubMed ID: 3289796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zellweger-like phenotype in two siblings: a defect in peroxisomal beta-oxidation with elevated very long-chain fatty acids but normal bile acids.
    Mandel H; Berant M; Aizin A; Gershony R; Hemmli S; Schutgens RB; Wanders RJ
    J Inherit Metab Dis; 1992; 15(3):381-4. PubMed ID: 1405475
    [No Abstract]   [Full Text] [Related]  

  • 25. Photosensitized killing of cultured fibroblasts from patients with peroxisomal disorders due to pyrene fatty acid-mediated ultraviolet damage.
    Hoefler G; Paschke E; Hoefler S; Moser AB; Moser HW
    J Clin Invest; 1991 Dec; 88(6):1873-9. PubMed ID: 1752949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phytanic acid and very long chain fatty acids in genetic peroxisomal disorders.
    Molzer B; Kainz-Korschinsky M; Sundt-Heller R; Bernheimer H
    J Clin Chem Clin Biochem; 1989 May; 27(5):309-14. PubMed ID: 2474624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolism of saturated and polyunsaturated fatty acids by normal and Zellweger syndrome skin fibroblasts.
    Street JM; Johnson DW; Singh H; Poulos A
    Biochem J; 1989 Jun; 260(3):647-55. PubMed ID: 2504148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of a homologous series of C26-C38 polyenoic fatty acids in the brain of patients without peroxisomes (Zellweger's syndrome).
    Poulos A; Sharp P; Singh H; Johnson D; Fellenberg A; Pollard A
    Biochem J; 1986 Apr; 235(2):607-10. PubMed ID: 3741408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic effects of docosahexaenoic acid ethyl ester in patients with generalized peroxisomal disorders.
    Martínez M; Vázquez E; García-Silva MT; Manzanares J; Bertran JM; Castelló F; Mougan I
    Am J Clin Nutr; 2000 Jan; 71(1 Suppl):376S-85S. PubMed ID: 10618001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Restoring the DHA levels in the brains of Zellweger patients.
    Martinez M
    J Mol Neurosci; 2001; 16(2-3):309-16; discussion 317-21. PubMed ID: 11478386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polyunsaturated fatty acids in the developing human brain, red cells and plasma: influence of nutrition and peroxisomal disease.
    Martinez M
    World Rev Nutr Diet; 1994; 75():70-8. PubMed ID: 7871835
    [No Abstract]   [Full Text] [Related]  

  • 32. Zellweger syndrome in a preterm, small for gestational age infant.
    Samsom JF; Jakobs C; van de Klei-van Moorsel J; Smit LM; Schutgens RB; Wanders RJ
    J Inherit Metab Dis; 1992; 15(1):75-83. PubMed ID: 1583879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Peroxisomal diseases: an analysis of ferritin levels in Zellweger's cerebrohepatorenal syndrome].
    Carrascosa-Romero MC; Vidal-Company A; Gil-Pons E; Perez-Pardo A; Marco-Giner J; Tebar-Gil R
    Rev Neurol; 2008 May 16-31; 46(10):636-7. PubMed ID: 18465705
    [No Abstract]   [Full Text] [Related]  

  • 34. Peroxisomes and peroxisomal functions in hyperpipecolic acidaemia.
    Wanders RJ; van Roermund CW; van Wijland MJ; Schutgens RB; Tager JM; van den Bosch H; Thomas GH
    J Inherit Metab Dis; 1988; 11 Suppl 2():161-4. PubMed ID: 3141699
    [No Abstract]   [Full Text] [Related]  

  • 35. Peroxisomal L-pipecolic acid oxidation is deficient in liver from Zellweger syndrome patients.
    Mihalik SJ; Moser HW; Watkins PA; Danks DM; Poulos A; Rhead WJ
    Pediatr Res; 1989 May; 25(5):548-52. PubMed ID: 2717271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders.
    Mayatepek E; Lehmann WD; Fauler J; Tsikas D; Frölich JC; Schutgens RB; Wanders RJ; Keppler D
    J Clin Invest; 1993 Mar; 91(3):881-8. PubMed ID: 8450067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain uptake and utilization of fatty acids: recommendations for future research.
    Katz R; Hamilton JA; Spector AA; Moore SA; Moser HW; Noetzel MJ; Watkins PA
    J Mol Neurosci; 2001; 16(2-3):333-5. PubMed ID: 11478387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The occurrence of polyenoic very long chain fatty acids with greater than 32 carbon atoms in molecular species of phosphatidylcholine in normal and peroxisome-deficient (Zellweger's syndrome) brain.
    Poulos A; Sharp P; Johnson D; Easton C
    Biochem J; 1988 Aug; 253(3):645-50. PubMed ID: 2845926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Peroxisomal disorders; newer concept and recent studies].
    Kamoshita S
    Nihon Rinsho; 1990 Mar; 48(3):629-38. PubMed ID: 2192101
    [No Abstract]   [Full Text] [Related]  

  • 40. Urinary polyamine and metabolite excretion by children with Zellweger's syndrome.
    Govaerts LC; van den Berg GA; Theeuwes A; Muskiet FA; Monnens LA
    Clin Chim Acta; 1990 Nov; 192(1):61-7. PubMed ID: 2261698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.